# Tetherex Pharmaceuticals Corp: Form D filings

Tetherex Pharmaceuticals Corp, a biotechnology company in Oklahoma City, OK, filed 5 Form D notices with the SEC between 2015 and 2020. The latest, on December 16, 2020, reports an offering of no set size with nothing sold yet to 1 investor.

Find out what Tetherex Pharmaceuticals Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Tetherex%20Pharmaceuticals%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Tetherex%20Pharmaceuticals%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Ftetherex-pharmaceuticals-corp-1634581)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Tetherex%20Pharmaceuticals%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Tetherex%20Pharmaceuticals%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Ftetherex-pharmaceuticals-corp-1634581)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Oklahoma](https://specstream.ai/data/form-d/state/oklahoma): 227 rows, by operating companies, filed since November 1, 2024, $11.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/oklahoma
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 840 RESEARCH PARKWAY, SUITE 516, Oklahoma City, OK, 73104
- Phone: (405) 319-8195
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1634581

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 16, 2020 | New notice | Indefinite | $0 | Indefinite | 1 | Dec 3, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1634581/000156761920021142/0001567619-20-021142-index.htm) |
| Mar 6, 2018 | New notice | $50,000,000 | $42,980,475 | $7,019,525 | 240 | Feb 20, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1634581/000114036118012258/0001140361-18-012258-index.htm) |
| Oct 9, 2015 | Amendment | $4,000,000 | $4,000,000 | $0 | 30 | May 18, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1634581/000114036115037309/0001140361-15-037309-index.htm) |
| Jun 17, 2015 | New notice | $4,000,000 | $600,000 | $3,400,000 | 2 | May 18, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1634581/000114036115024549/0001140361-15-024549-index.htm) |
| Feb 23, 2015 | New notice | $1,262,722 | $1,262,722 | $0 | 14 | Feb 9, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1634581/000114036115008405/0001140361-15-008405-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Scott Rollins, Ph.D. | Executive Officer, Director |  |
| Rodger McEver, M.D. | Director |  |
| Richard Alvarez | Executive Officer |  |
| Scott Samara | Director |  |
| Philip Jones, M.D. | Director |  |
| Russell Rother, Ph.D. | Executive Officer, Director |  |
| Todd Foley | Director |  |
| David Keiser | Director |  |
| Jonathan Stocker, Ph.D. | Executive Officer |  |

## Other biotechnology companies in Oklahoma that filed recently

- [Endless Corp](https://specstream.ai/data/form-d/company/endless-corp-2043905) $100,000 · Aug 19, 2026

[Every Form D from the week of Dec 14, 2020](https://specstream.ai/data/form-d/week/2020-12-14) · [All recent filings in Oklahoma](https://specstream.ai/data/form-d/state/oklahoma) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Tetherex Pharmaceuticals Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).